Publications | Lund University Publications

301 – 310 of 354

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=keywords+exact+%22prostate+cancer%22&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
30
31
32
33
…
36
next »

2007
Mark A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancer
Carducci, Michael A. ; Saad, Fred ; Abrahamsson, Per-Anders ^LU ; Dearnaley, David R. ; Schulman, Claude C. ; North, Scott A. ; Sleep, Darryl J. ; Isaacson, Jeffrey D. and Nelson, Joel B. (2007) In Cancer 110(9). p.1959-1966
- Contribution to journal › Article
Mark What should a urologist know about hereditary predisposition to prostate cancer?
Bratt, Ola ^LU (2007) In BJU International 99(4). p.743-747
- Contribution to journal › Scientific review
Mark The continuing role of PSA in the detection and management of prostate cancer
Miller, Kurt ; Abrahamsson, Per-Anders ^LU ; Akakura, Koichiro ; Debruyne, Frans M. J. ; Evans, Christopher P. and Klotz, Laurence (2007) In European Urology. Supplement 6(3). p.327-333
- Contribution to journal › Article
Mark NMR STUDIES ON STRUCTURE AND DYNAMICS OF TWO-DOMAIN PROTEINS
Ghasriani, Houman ^LU (2007)
- Thesis › Doctoral thesis (compilation)
2006
Mark Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hk2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum
Steuber, T ; Vickers, AJ ; Haese, A ; Becker, Charlotte ^LU ; Pettersson, K ; Chun, FKH ; Kattan, MW ; Eastham, JA ; Scardino, PT and Huland, H , et al. (2006) In International Journal of Cancer 118(5). p.1234-1240
- Contribution to journal › Article
Mark Tolerability, efficacy and pharmacokinetics of bicalutamide 300 mg, 450 mg or 600 mg as monotherapy for patients with locally advanced or metastatic prostate cancer, compared with castration
Tyrrell, Chris J. ; Iversen, Peter ; Tammela, Teuvo ; Anderson, John ; Björk, Thomas ^LU ; Kaisary, Amir V. and Morris, Thomas (2006) In BJU International 98(3). p.563-572
- Contribution to journal › Article
Mark The Prostate Cancer Prevention Trial and its implications for clinical practice: A European consensus
Teillac, Pierre and Abrahamsson, Per-Anders ^LU (2006) In European Urology. Supplement 5(9). p.640-646
- Contribution to journal › Article
Mark Hormone therapy: Improving therapy decisions and monitoring
Zlotta, AR ; Abrahamsson, Per-Anders ^LU ; Tombal, B ; Berges, R and Debruyne, F (2006) In European Urology. Supplement 5(3). p.369-376
- Contribution to journal › Article
Mark CYSTATIN C AND NEUROENDOCRINE DIFFERENTIATION IN THE MALE REPRODUCTIVE SYSTEM AND IN PROSTATE CANCER
Jiborn, Thomas ^LU (2006)
- Thesis › Doctoral thesis (compilation)
Mark Octreotide scintigraphy and Chromogranin A do not predict clinical response in patients with octreotide acetate-treated hormone-refractory prostate cancer
Kalkner, Karl Mikael ; Acosta, Stefan ^LU ; Thorsson, Ola ^LU ; Frederiksen, Hans ^LU ; Nilsson, A ; Gustavsson, Bengt ; Elingsbo, Marie ; Stridsberg, M and Abrahamsson, Per-Anders ^LU (2006) In Prostate Cancer and Prostatic Diseases 9(1). p.92-98
- Contribution to journal › Article

« previous
1
…
30
31
32
33
…
36
next »

your query:: Remove keywords: prostate cancer